Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 10351-10400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06597006
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
PHASE3Recruiting
9 participants
Started: Feb 28, 2025 · Completed: Apr 15, 2029
1 condition1 sponsor15 locations
NCT06894212
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
PHASE3Recruiting
522 participants
Started: Feb 28, 2025 · Completed: Oct 29, 2026
1 condition1 sponsor35 locations
NCT06664528
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
N/ARecruiting
300 participants
Started: Feb 28, 2025 · Completed: Dec 15, 2028
2 conditions1 sponsor1 location
NCT06858189
Promoting Active Therapy: Path to Wellness
PHASE2Recruiting
60 participants
Started: Feb 28, 2025 · Completed: May 31, 2026
5 conditions2 sponsors1 location
NCT06819436
Effect of Dexamethasone on Post-spinal Hypotension
PHASE4Recruiting
170 participants
Started: Feb 28, 2025 · Completed: May 31, 2025
3 conditions1 sponsor1 location
NCT06886516
Apixaban in Thrombocytopenia
EARLY_PHASE1Recruiting
30 participants
Started: Feb 28, 2025 · Completed: Jul 1, 2028
4 conditions1 sponsor1 location
NCT06523621
Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
PHASE2Recruiting
50 participants
Started: Feb 28, 2025 · Completed: Nov 30, 2027
1 condition3 sponsors2 locations
NCT06685237
Copenhagen Heart Failure With Preserved Ejection Fraction
N/ARecruiting
5,000 participants
Started: Feb 28, 2025 · Completed: Mar 28, 2026
1 condition1 sponsor1 location
NCT06848465
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
PHASE1Recruiting
9 participants
Started: Feb 28, 2025 · Completed: Nov 30, 2027
3 conditions1 sponsor2 locations
NCT06867016
Effects of Bidomain Cognitive and Aerobic Training on Cognitive Functioning in Mild Cognitive Impairment.
NARecruiting
44 participants
Started: Feb 28, 2025 · Completed: Aug 28, 2025
1 condition1 sponsor1 location
NCT06863350
Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale(PREDICT-PFO Trial)
NARecruiting
180 participants
Started: Feb 28, 2025 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT06771284
Problem Behavior Assessment and Intervention in IDEA Part C Services
NARecruiting
9 participants
Started: Feb 28, 2025 · Completed: May 31, 2025
3 conditions2 sponsors1 location
NCT06816771
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
PHASE2Recruiting
38 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06633562
A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults
PHASE1Recruiting
32 participants
Started: Feb 28, 2025 · Completed: Dec 1, 2025
3 conditions2 sponsors1 location
NCT06703060
A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
NARecruiting
300 participants
Started: Feb 28, 2025 · Completed: Feb 29, 2028
4 conditions2 sponsors1 location
NCT06736717
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
PHASE1/PHASE2Recruiting
21 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06736925
Omega-3 Fatty Acids and Subconcussive Head Impacts
NARecruiting
208 participants
Started: Feb 28, 2025 · Completed: May 31, 2029
2 conditions2 sponsors1 location
NCT07075159
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
NARecruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT06762782
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
PHASE2Recruiting
276 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2027
2 conditions11 sponsors1 location
NCT06792071
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
NARecruiting
18 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2027
4 conditions4 sponsors1 location
NCT06840249
Pediatric Vascular Trauma
N/ARecruiting
75 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06774534
SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome
N/ARecruiting
40 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT06735053
Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients
NARecruiting
26 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2025
1 condition1 sponsor2 locations
NCT06768749
The Impact of Melatonin Lotion on Sleep and Mental Health
NARecruiting
60 participants
Started: Feb 28, 2025 · Completed: Apr 1, 2028
2 conditions1 sponsor1 location
NCT06812390
Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
PHASE2Recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT06761924
Predicting Ultrasound-Guided Thoracic PVB Success in Herpetic Neuralgia
NARecruiting
140 participants
Started: Feb 28, 2025 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06658145
Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy
NARecruiting
94 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06867393
Safety, Tolerability, and Pharmacokinetics of HL-003 in Healthy Subjects
PHASE1Recruiting
52 participants
Started: Feb 28, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06773312
BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
PHASE1Recruiting
80 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2027
2 conditions2 sponsors1 location
NCT07125248
Outcomes of a Single Chest Drain vs Two Drains
NARecruiting
68 participants
Started: Feb 28, 2025 · Completed: Sep 10, 2025
3 conditions1 sponsor1 location
NCT06830642
Study of the Oral Treatment MTR-601 in Cervical Dystonia
PHASE2Recruiting
80 participants
Started: Feb 28, 2025 · Completed: Aug 3, 2026
1 condition1 sponsor17 locations
NCT06977009
Influence of Occlusal Reduction on Endodontic Postoperative Pain
NARecruiting
60 participants
Started: Feb 28, 2025 · Completed: Jul 20, 2025
1 condition1 sponsor1 location
NCT06856577
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
PHASE3Recruiting
284 participants
Started: Feb 28, 2025 · Completed: Mar 25, 2030
2 conditions1 sponsor79 locations
NCT06921902
Glycemic Metrics and Patterns in People With and Without Prediabetes
N/ARecruiting
2,000 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06753370
Experiences of Managing Sleep Disordered Breathing in Children With Cerebral Palsy.
N/ARecruiting
20 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2026
3 conditions1 sponsor2 locations
NCT06922955
A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.
N/ARecruiting
400 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor35 locations
NCT06797024
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NARecruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04211753
Effectiveness and Security Testing of a Mobile App (B·RIGHT) for Emotional Crisis in Borderline Personality Disorder
NARecruiting
80 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06831929
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NARecruiting
2,232 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06201676
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
PHASE4Recruiting
458 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors2 locations
NCT06812988
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
PHASE2Recruiting
84 participants
Started: Feb 28, 2025 · Completed: Sep 13, 2028
1 condition1 sponsor23 locations
NCT06764316
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
PHASE1Recruiting
148 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2033
1 condition1 sponsor10 locations
NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
PHASE1Recruiting
90 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
11 conditions1 sponsor15 locations
NCT06768476
CART123 + Ruxolitinib in Relapsed/Refractory AML
PHASE1Recruiting
12 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2045
2 conditions2 sponsors1 location
NCT06673043
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
N/ARecruiting
100 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor11 locations
NCT06852209
Training Cognition With Neurofeedback After Stroke
NARecruiting
20 participants
Started: Feb 28, 2025 · Completed: Nov 28, 2026
2 conditions1 sponsor1 location
NCT06923371
Moms and Babies Health and Well-being
NARecruiting
1,250 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06858696
A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function
PHASE1Recruiting
48 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor4 locations
NCT06942416
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
PHASE2Recruiting
36 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06610266
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
PHASE4Recruiting
400 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor1 location